Rees MG, Seashore-Ludlow B, Clemons PA. Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines. Methods Mol Biol. 2019;1888:233-254. doi:10.1007/978-1-4939-8891-4_14
Fitipaldi H, McCarthy MI, Florez JC, Franks PW. A Global Overview of Precision Medicine in Type 2 Diabetes. Diabetes. 2018;67(10):1911-1922. doi:10.2337/dbi17-0045
Phuah CL, Dave T, Malik R, et al. Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke. Brain. 2017;140(10):2663-2672. doi:10.1093/brain/awx220
Seiler KP, George GA, Happ MP, et al. ChemBank: a small-molecule screening and cheminformatics resource database. Nucleic Acids Res. 2008;36(Database issue):D351-9. doi:10.1093/nar/gkm843
Boycott KM, Rath A, Chong JX, et al. International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases. Am J Hum Genet. 2017;100(5):695-705. doi:10.1016/j.ajhg.2017.04.003
Emdin CA, Klarin D, Natarajan P, et al. Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease. Diabetes. 2017;66(8):2310-2315. doi:10.2337/db17-0149
Wawer M, Peltason L, Bajorath J. Elucidation of structure-activity relationship pathways in biological screening data. J Med Chem. 2009;52(4):1075-80. doi:10.1021/jm8014102
Lounkine E, Wawer M, Wassermann AM, Bajorath J. SARANEA: a freely available program to mine structure-activity and structure-selectivity relationship information in compound data sets. J Chem Inf Model. 2010;50(1):68-78. doi:10.1021/ci900416a
Galat A, Lane WS, Standaert RF, Schreiber SL. A rapamycin-selective 25-kDa immunophilin. Biochemistry. 1992;31(8):2427-34.
Strausberg RL, Schreiber SL. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science. 2003;300(5617):294-5. doi:10.1126/science.1083395